Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALDX

Aldeyra Therapeutics Inc

Jun 18 • 04:00PM ET

1.96

+0.13 7.10 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: AARD AGEN CNTB GALT IMUX KZIA NTHI SPRO VANI VRCA

| Held by: VTI IWM VXF IWO VTWO IWC VHT DFMC PRFZ ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.46	Insider Own	3.70%	Shs Outstand	60.32M	Perf Week	14.62%
Market Cap	118.23M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	17.04%	Shs Float	58.09M	Perf Month	27.27%
Enterprise Value	68.74M	PEG	-	EPS next Q	-0.10	Inst Own	62.26%	Short Float	13.69%	Perf Quarter	7.10%
Income	-27.37M	P/S	-	EPS this Y	27.68%	Inst Trans	-7.45%	Short Ratio	3.76	Perf Half Y	-63.09%
Sales	0.00M	P/B	2.80	EPS next Y	48.97%	ROA	-34.28%	Short Interest	7.95M	Perf YTD	-62.16%
Book/sh	0.70	P/C	1.82	EPS next 5Y	62.30%	ROE	-51.76%	52W High	6.18 -68.26%	Perf Year	-38.17%
Cash/sh	1.08	P/FCF	-	EPS past 3/5Y	19.04% 12.61%	ROIC	-64.92%	52W Low	1.07 83.18%	Perf 3Y	-81.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.08% 7.89%	Perf 5Y	-83.56%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	53.00%	Oper. Margin	-	ATR (14)	0.14	Perf 10Y	-63.36%
Dividend Ex-Date	-	Quick Ratio	2.69	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	62.26	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.69	EPS Q/Q	65.50%	SMA20	13.20%	Beta	1.17	Target Price	7.00
Payout	-	Debt/Eq	0.37	Sales Q/Q	-	SMA50	15.53%	Rel Volume	1.03	Prev Close	1.83
Employees	8	LT Debt/Eq	0.00	Earnings	Apr 30	SMA200	-50.64%	Avg Volume	2.12M	Price	1.96
IPO	May 02, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.46% -	Trades		Volume	2,182,813	Change	7.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)